The third quarter marked contrasting financial outcomes for four of the largest for-profit health systems in the country. While HCA Healthcare and Tenet Healthcare reported strong growth in ...

Sonny with a Chance and all series produced since 2009, as well as seasons of existing series produced before 2009 that continued into that year were produced in high definition, but all series shot ...

Fellow hospital company Universal Health Services (UHS) also disclosed quarterly results. Although revenue came in slightly ahead of estimates, profits were lower than expected. Increased ...

Universal Health Services (UHS) came out with quarterly earnings of $3.71 per share, missing the Zacks Consensus Estimate of $3.75 per share. This compares to earnings of $2.55 per share a year ago.

Oct 23 (Reuters) - Apple (AAPL.O), opens new tab has sharply scaled back its Vision Pro production since early summer and could stop making the existing version of the mixed reality headset by ...

Enter Australia, which has aggressively been courting the production to relocate. It was a tempting proposition. The burgeoning film hub, unlike California, allows unscripted programming to ...

Adar Poonawalla-led Serene Productions has announced that it has entered into a binding agreement to invest ₹1,000 crore into Karan Johar’s Dharma Productions and Dharmatic Entertainment.

Karan Johar's Dharma Productions sells 50% stake to Adar Poonawalla: The deal, valued at Rs 1,000 crore, will see Poonawalla's Serene Production acquire a 50% stake in the renowned production house, ...

Business tycoon Adar Poonawalla has acquired a 50% stake in Karan Johar's Dharma Productions and Dharmatic Entertainment (collectively known as Dharma). According to a press note released by ...

Pharmaceutical tycoon Adar Poonawalla’s Serene Productions is investing $119 million in Indian media personality Karan Johar‘s Dharma Productions and Dharmatic Entertainment. The deal values ...

Adar Poonawalla is acquiring a 50% stake in Karan Johar's Dharma Productions for 1000 crore, allowing Johar to maintain creative control. Adar Poonawalla, CEO of the Serum Institute of India ...